Is KAPA or KPTI more undervalued in 2026?

CirclFi compares Kairos Pharma, Ltd. (KAPA) and Karyopharm Therapeutics Inc. (KPTI) using 13 institutional-grade valuation models. KAPA has a Quality of Company score of 4.6/10 while KPTI scores 5.1/10.

Which is a better buy — KAPA or KPTI?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do KAPA and KPTI valuations compare?

KAPA at $0.51 and KPTI at $9.10 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

KAPA vs KPTI Valuation Comparison 2026 — Intrinsic Value Analysis

KAPA

Pharmaceutical Preparations

Kairos Pharma, Ltd.

Quality

4.6

out of 10

Value Trap

SAFE

Price

$0.51

Last close

Models

7/13

Active

KPTI

Pharmaceutical Preparations

Karyopharm Therapeutics Inc.

Quality

5.1

out of 10

Value Trap

LOW

Price

$9.10

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	KAPA Fair Value	KAPA Upside	KPTI Fair Value	KPTI Upside
Bayesian DCF	Intrinsic	$0.19	-62.4%	$3.13	-65.6%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$0.23	-55.4%	—	—
PWERM	Option-Based	$0.49	-4.0%	$23.88	+162.4%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for KAPA vs KPTI — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

KAPA vs KPTI — Which Stock Is More Undervalued?

KPTI scores higher with a 5.1/10 quality rating vs KAPA's 4.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Kairos Pharma, Ltd. (KAPA) and Karyopharm Therapeutics Inc. (KPTI) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

KAPA currently trades at $0.51 with a QOC of 4.6/10, while KPTI trades at $9.10 with a QOC of 5.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).